Learning Objectives:

• Improve understanding of the burden and clinical significance of menopause-related symptoms—including vasomotor symptoms (VMS), sleep disturbances, and weight fluctuations—in women with breast cancer receiving endocrine therapy
• Review evidence from the OASIS clinical program for non-hormonal management of vasomotor symptoms
• Provide practical, patient-centered strategies for managing vasomotor symptoms, sleep disturbances, and weight changes when hormone therapy is contraindicated
• Integrate patient-centered approaches to optimize quality of life and treatment adherence throughout the breast cancer journey

Agenda:

• Introduction – Prof. Hope Rugo (Chair)
• Patient Experience: Living with Menopause Symptoms During Breast Cancer Treatment – Dr. Kelly Shanahan
• Understanding the Burden of Menopause in Breast Cancer Patients – Dr. Maryam Lustberg
• Evidence Update: OASIS 1–4 & Non-Hormonal Management Options – Dr. Milana Dolezal
• Practical Management of Sleep Disturbances & Weight Changes - Brittany Bradford, Nurse Practitioner
• Q & A

 This webinar was made possible by an unrestricted educational grant provided by Bayer.